These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
533 related items for PubMed ID: 14730270
1. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection. Johnson TR, Graham BS. Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S46-57. PubMed ID: 14730270 [Abstract] [Full Text] [Related]
11. Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the Bonnet monkey model. Ponnuraj EM, Springer J, Hayward AR, Wilson H, Simoes EA. J Infect Dis; 2003 Apr 15; 187(8):1257-63. PubMed ID: 12696005 [Abstract] [Full Text] [Related]
12. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice. Fu Y, He J, Zheng X, Wu Q, Zhang M, Wang X, Wang Y, Xie C, Tang Q, Wei W, Wang M, Song J, Qu J, Zhang Y, Wang X, Hong T. Biochem Biophys Res Commun; 2009 Apr 17; 381(4):528-32. PubMed ID: 19233131 [Abstract] [Full Text] [Related]
13. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. Graham BS, Henderson GS, Tang YW, Lu X, Neuzil KM, Colley DG. J Immunol; 1993 Aug 15; 151(4):2032-40. PubMed ID: 8345194 [Abstract] [Full Text] [Related]
14. Immune responses to the nonglycosylated ectodomain of respiratory syncytial virus attachment glycoprotein mediate pulmonary eosinophilia in inbred strains of mice with different MHC haplotypes. Hancock GE, Tebbey PW, Scheuer CA, Pryharski KS, Heers KM, LaPierre NA. J Med Virol; 2003 Jun 15; 70(2):301-8. PubMed ID: 12696122 [Abstract] [Full Text] [Related]
15. Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity. Ostler T, Ehl S. Eur J Immunol; 2002 Sep 15; 32(9):2562-9. PubMed ID: 12207340 [Abstract] [Full Text] [Related]
17. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. Mottram PL, Leong D, Crimeen-Irwin B, Gloster S, Xiang SD, Meanger J, Ghildyal R, Vardaxis N, Plebanski M. Mol Pharm; 2007 Sep 15; 4(1):73-84. PubMed ID: 17274665 [Abstract] [Full Text] [Related]
18. Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus. Valosky J, Hishiki H, Zaoutis TE, Coffin SE. Clin Diagn Lab Immunol; 2005 Jan 15; 12(1):171-9. PubMed ID: 15643003 [Abstract] [Full Text] [Related]
19. Induction of balanced immunity in BALB/c mice by vaccination with a recombinant fusion protein containing a respiratory syncytial virus G protein fragment and a CTL epitope. Zeng RH, Gong W, Fan CF, Wang YF, Mei XG. Vaccine; 2006 Feb 13; 24(7):941-7. PubMed ID: 16159685 [Abstract] [Full Text] [Related]